TABLE 1.
Demographics and clinical characteristics of the study participants (n = 119).
| Adherence (n = 86) | Non-adherence (n = 33) | χ 2 | P | |
|---|---|---|---|---|
| Age, M (IQR), yr | 12.67 (9.65–13.92) | 12.58 (8.17–15.71) | −0.59 a | 0.56 |
| Gender, n (%) | 1.51 | 0.22 | ||
| Male | 55 (63.95) | 25 (75.76) | ||
| Female | 31 (36.05) | 8 (24.24) | ||
| Diagnosis, n (%) | 0.85 | 0.65 | ||
| CD | 70 (81.40) | 25 (75.76) | ||
| UC | 10 (11.63) | 4 (12.12) | ||
| VEO-IBD | 6 (6.98) | 4 (12.12) | ||
| IBD duration, n (%) | 6.19 | 0.05 | ||
| 3 months-1 year | 40 (46.51) | 10 (30.30) | ||
| 1–3 years | 34 (39.53) | 12 (36.36) | ||
| 3 years and above | 12 (13.95) | 11 (33.33) | ||
| Disease severity, n (%) | 5.43 | 0.14 | ||
| Remission | 52 (60.47) | 22 (66.67) | ||
| Mild | 19 (22.09) | 10 (30.30) | ||
| Moderate | 12 (13.95) | 0 (0.00) | ||
| Severe | 3 (3.49) | 1 (3.03) | ||
| No. Of IBD medications, n (%) | 0.05 | 0.82 | ||
| 1 medication | 81 (94.19) | 30 (90.91) | ||
| 2 or more medications | 5 (5.81) | 3 (9.09) | ||
| Medication frequency, n (%) | 0.20 | 0.66 | ||
| Once a day or less | 70 (81.40) | 28 (84.85) | ||
| Twice a day or more | 16 (18.60) | 5 (15.15) | ||
| Health insurance, n (%) | 0.29 | 0.87 | ||
| No health insurance | 20 (23.26) | 9 (27.27) | ||
| Rural new cooperative medical scheme | 38 (44.19) | 13 (39.39) | ||
| Urban resident basic medical insurance | 28 (32.56) | 11 (33.33) | ||
| Average monthly income, n (%) | 0.10 | 0.61 | ||
| Less than RMB 2500 | 22 (25.58) | 10 (30.30) | ||
| RMB 2500–5000 | 38 (44.19) | 16 (48.48) | ||
| More than RMB 5000 | 26 (30.23) | 7 (21.21) | ||
| Parental CCKNOW score, M (IQR) | 9.00 (6.75–11.00) | 5.00 (3.50–8.00) | −4.04 a | 0.00 |
CD, Crohn disease; UC, Ulcerative Colitis.
VEO-IBD: very early onset inflammatory bowel disease; IBD: inflammatory bowel disease.
CCKNOW: Crohn’s and Colitis Knowledge questionnaire.
a
Mann-Whitney test.